Article
14 Nov 2025
M&A In GLP-1 Technology: Practical Recommendations And Best Practices
AUTHORS CONTENT
Article
05 Jun 2025
GLP-1 Receptor Agonists: The Surge Of M&A Activity And The Future Of Metabolic Health
Article
14 Mar 2025
Leveraging USPTO Delays To Maximize Patent Term
Article
17 Dec 2024
Antibody Drug Conjugates Keep Growing: What You Need To Know
Article
10 Jun 2024
Cancer Drugs: Deals And Licensing For Antibody-Drug Conjugates
Article
13 Dec 2023
FDA Approves Two Gene Therapies To Treat Sickle Cell Disease Including A CRISPR-Based Therapy
Article
22 Oct 2016
Timing Is Everything: Successful Joinder Motions At The PTAB
Article
03 Nov 2009
Biosimilars Provision Included In House Health Care Reform Bill - The Time Has Finally Come